aspirin - Generic mfg.
Dupixent (dupilumab) - Sanofi, Regeneron
Amoebiasis in Nasal polyposis Aspirin-exacerbated respiratory disease Asthma Patient Undergoing Dupilumab Treatment (ACAAI 2026) - Oct 28, 2026 - Abstract #M121; Pres time: Nov 15, 2026; 12:00 PM - 01:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 1; No abstract available 
Clinical • Asthma • Immunology • Nasal Polyps • Otorhinolaryngology • Respiratory Diseases
https://annualmeeting.acaai.org/2026/submit_abstract.cfm
 
Oct 28, 2026
 
Prev Next